Urine metabolite analysis as a function of deoxynivalenol exposure: An NMR-based metabolomics investigation

Food Additives and Contaminants - Part A

Volumn 27, Issue 2, 2010, Pages 255-261

  Hopton, R P ^a,b   Turner, E ^a   Burley, V J ^b   Turner, P C ^b   Fisher, J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Analysis nuclear magnetic resonance (NMR); Beer; Bread; Cereals and grain; Exposure; Mycotoxins Fusarium; Mycotoxins trichothecenes

Indexed keywords

CREATININE; HIPPURIC ACID; VOMITOXIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; FEMALE; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; URINALYSIS; URINE LEVEL;

FUSARIUM; HORDEUM; TRITICUM AESTIVUM; ZEA MAYS;

EID: 71649105302     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/19440040903314015     Document Type: Article

References (37)

1. Bhat RV, Ramakrishna Y, Beedu SR, Munshi KL. 1989. Outbreak of trichothecene mycotoxicosis associated with consumption of mold-damaged wheat products in Kashmir Valley, India. Lancet. 1: 35-37.
2. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. 2005. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18:143-162.
3. Brewster D, Jones RS, Parke DV. 1978. Metabolism of shikimate in rat. Biochem J. 170:257-264.
4. Canady RA, Coker RD, Egan SK, Krska R, Kuiper-Goodman T, Olsen M, Pestka J, Resnik S, Schlatter J. 2001. Deoxynivalenol. In: Safety evaluation of certain mycotoxins in food. Geneva (Switzerland). World Health Organization. p. 420-529.
5. 1H-NMR spectroscopic metabonomic studies. Anal Chem. 77(2):517-526.
6. Coen M, Holmes E, Lindon JC, Nicholson JK. 2008. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 21:9-27.
7. 1H-NMR based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers. 9:156-179.
8. Council for Agriculture Science and Technology (CAST). 2003. Potential economic costs of mycotoxins in the United States. In: Mycotoxins: Risks in plant, animal, and human systems. Task Force Report No. 139. Ames (IA): CAST. p. 136-142.
9. Craig A, Cloarec O, Holmes E, Nicholson JK, Lindon JC. 2006. Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Anal Chem. 78: 2262-2267.
10. Forshed J, Schuppe-Koistinen I, Jacobsson SP. 2003. Peak alignment of NMR signals by means of a genetic algorithm. Anal Chim Acta. 487(2):189-199.
11. Goyarts T, Danicke S. 2006. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol Lett. 163(3):171-182.
12. Gu HW, Chen HW, Pan ZZ, Jackson AU, Talaty N, Xi BW, Kissinger C, Duda C, Mann D, Raftery D, Cooks RG. 2007. Monitoring diet effects via biofliuds and the implications for metabolomics studies. Anal Chem. 79: 89-97.
13. 1H-NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharmaceut Biomed. 15: 1647-1659.
14. Holmes E, Nicholson JK, Nicholls AW, Lindon JC, Connor SC, Polley S, Connelly J. 1998. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemom Intell Lab Syst. 44:245-255.
15. Jackson LS, Bullerman LB. 1999. Effect of processing on Fusarium mycotoxins. Adv Exp Med Biol. 459:243-261.
16. Ji PJ, Feng W, Tan TW, Zheng DX. 2007. Modeling of water activity, oxygen solubility and density of sugar and sugar alcohol solutions. Food Chem. 104:551-558.
17. Kasuya F, Igarashi K, Fukui M, Nokihara K. 1996. Purification and characterization of a medium chain acyl-coenzyme a-synthetase. Drug Metab Dispos. 24:879-883.
18. Lindon JC, Nicholson JK, Holmes E, Bollard ME, Stanley EG. 2004. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers. 9:1-31.
19. Lindon JC, Nicholson JK, Holmes E, Everett JR. 2000. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magnetic Res. 12:289-320.
20. Lord RS, Bralley JA. 2008. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Alt Med Rev. 13:292-306.
21. Luo X. 1994. Food poisoning caused by Fusarium toxins. In: Proceedings of the 2nd Asian Conference Food Safety; 1994; Chatuchak. Thailand. International Life Sciences Institute. p. 129-136.
22. Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild CP. 2003. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol. 41:265-273.
23. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicology Environ Health B Crit Rev. 8:39-69.
24. Phipps AN, Stewart J, Wright B, Wilson ID. 1998. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica. 28:527-537.
25. SCOOP. 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. SCOOP Task 3.2.10 Final report. Available from: http://europa.eu.int/comm/ food/fs/scoop/task3210.pdf/.
26. Smith LM, Maher AD, Want EJ, Elliott P, Stamler J, Hawkes GE, Holmes E, Lindon JC, Nicholson JK. 2009. Large scale human metabolic phenotyping and molecular epidemiological studies via 1H-NMR spectroscopy of urine: investigation of borate preservation. Anal Chem. 81:4847-4856.
27. Spaapen LJM, Ketting D, Wadman SK, Bruinvis L, Duran M. 1987. Urinary D-4-hydroxyphenyllactate, D-phenyllactate and D-2-hydroxyisocaproate, abnormalities of bacterial origin. J Inher Metab Dis. 10:383-390.
28. Sugita-Konsihi Y, Tanaka T, Tabata S, Nakajima M, Nouno M, Nakaie Y, Chonan T, Aoyagi M, Kibune N, Mizuno K, Ishikuro E, Kanamaru N, Minamisawa M, Aita N, Kushiro M, Tanaka K, Takatori K. 2006. Validation of an HPLC analytical method coupled to a multifunctional clean-up column for the determination of deoxynivalenol. Mycopathologia. 161:239-243.
29. Sundstol-Eriksen GS, Pettersson H. 2003. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam. 20:579-582.
30. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. 2008a. Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Expos Sci Environ Epidemiol. 18:392-399.
31. Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. 2008c. Deoxynivalenol: Rationale for development and application of a urinary biomarker. Food Addit Contam. 25:864-871.
32. Turner PC, Rothwell JA, White KLM, Gong YY, Cade JE, Wild CP. 2008b. Urinary dexoynivalenol is correlated with cereal intake from the UK. Environ Health Perspec. 116:21-25.
33. Wache YJ, Valat C, Postollec G, Bougeard S, Burel C, Oswald IP, Fravalo P. 2009. Impact of deoxynivalenol on the intestinal microflora of pigs. Int J Mol Sci. 10:1-17.
34. Wakai A, Roberts I, Schierhout G. 2007. Mannitol for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001049. DOI: 10.1002/14651858.CD001049.pub4. Available from: http://www. cochrane.org/reviews/en.a.b001049.html/
35. 1H-NMR spectros- copy of intact tissue and pattern recognition. J Pharm Biomed Anal. 40:375-381.
36. Yoshizawa T, Cote LM, Swanson SP, Buck WB. 1986. Confirmation of DOM-1, a de-epoxidation metabolite of deoxynivalenol, in biological fluids of lactating cows. Agric Biol Chem. 50:227-229.
37. 1H-NMR spectra of normal urines: Reference ranges of the major metabolites. Clin Chim Acta. 265:85-97.